arrow
E

Emily F. Davis-Marcisak

moderna inc
H指数:22
被引数:2,030

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The mRNA-based RSV vaccine mRNA-1345 induces robust and durable CD4+ T cell responses against RSV in younger and older adults

mRNA基RSV疫苗mRNA-1345在年轻和年长成人中诱导针对RSV的强效且持久的CD4+ T细胞应答

2026-10-210
OAAI
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

携带双检查点阻断的突变KRAS疫苗在切除的胰腺癌中的应用:一项I期临床试验

2026-02-100
OAAI
Comparative assessment of physiochemical metrics for the clustering of adaptive immune receptor repertoires

适应性免疫受体库聚类中物理化学指标的对比评估

2025-11-260
OAAI
CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial

CD137激动作用增强了新辅助性胰腺癌临床试验中抗PD-1诱导的扩增CD8+ T细胞克隆的激活。

2025-01-011
PRE
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy
2023-12-087
OA
Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R and GenePattern Notebook implementations of CoGAPS
2023-11-213
OA
Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo
2022-07-0514
OAAI
Mice with gene alterations in the GH and IGF family
2021-11-1928
OAAI
Community-wide hackathons to identify central themes in single-cell multi-omics (vol 22, 220, 2021)
2021-08-250
OAAI
Community-wide hackathons to identify central themes in single-cell multi-omics
2021-08-057
OAAI
Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies
2020-10-2128
OAAI